A clinical trial to study the effectiveness of medicated enema therapy and oral medication in the management of urinary problems specifically kidney disease.

An open label clinical trial to evaluate the efficacy of Basti Karma along with Shaman Yoga in the management of Mutravaha Sroto Dushti with special reference to Chronic Renal Failure - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087059

Enrollment

Registered

2025-05-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having any clinical signs and symptoms of chronic kidney disease. Patients having any clinical signs and symptoms of Mutravaha Sroto Dushti like Atibaddha or Atisrsta Mutra, Abhikshna or Alpalapa Mutra,Bahala Mutra and Sashula Mutra. Patients of Serum creatinine level 1.2 to 6 mg/dl. Patients of Albuminuria with ACR level greater than 30 mg/g . Patients of Blood urea level upto 48 to 180mg/dl Patients with GFR level less than 60 ml/min/1.73m and persistent ,present for more than 3 months

Exclusion criteria

Exclusion criteria: Patients who are on dialysis treatment from more than 1-month period. Patients who are already operated for renal transplantation. Patients of end stage renal failure. Female patients having pregnancy, breast feeding or post-delivery period. Patients with Haemoglobin less than 7gm/dl Patients with HbA1C greater than 9% and uncontrolled Hypertension. Patients with serious cardiovascular illness , acute mental disorder, serious chronic co-morbidity, hepato-renal insufficiency, liver or metabolic disorders etc.

Design outcomes

Primary

Measure	Time frame
Primary Outcome: Changes in RFT and eGFR at the end of trial. Timepoint: Patient will be assesed at the baseline,30th day and during follow up on 45th day.	—

Secondary

Measure	Time frame
Secondary Outcome: Symptomatic relief in patients & changes in urine output at the end of trial.Timepoint: Patient will be assesed on the baseline ,30th day & during follow up on 45th day.	—

Countries

India

Contacts

Public ContactProfessor Dr Gopesh Mangal

National Institute of Ayurveda

gmangal108@gmail.com8619849011

Outcome results